KIT	N505I	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib; 1: Ripretinib;
BRAF	V600E	Anaplastic Thyroid Cancer	1: Dabrafenib+Trametinib;
BRAF	V600E	Histiocytosis	3A: Vemurafenib; 3A: Dabrafenib;
BRAF	G464A	Anaplastic Thyroid Cancer	4: PLX8394;
BRAF	G464A	Histiocytosis	3A: Cobimetinib; 3A: Trametinib;
AKT1	E17K	Breast Cancer	3A: AZD5363;
AKT1	E17K	NSCLC	3B: AZD5363;
AKT1	E17G	Breast Cancer
FGFR3	Y373C	Bladder Cancer	1: Erdafitinib;
RET	KIF5B-RET Fusion	NSCLC	1: Selpercatinib; 1: Pralsetinib;
RET	KIF5B-RET Fusion	Bladder Cancer	3B: Cabozantinib; 3B: Vandetanib; 3B: Selpercatinib; 3B: Pralsetinib;
